From Despair to Hope: First Arabic Experience of

161Tb-PSMA 177Lu-PSMA PRLT PSA PSMA therapy PSMA-RLT mCRPC prostate cancer radioligand therapy specific membrane antigen

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 May 2024
Historique:
received: 23 04 2024
revised: 18 05 2024
accepted: 20 05 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: epublish

Résumé

The objective of this retrospective study is to assess the effectiveness and safety of two beta-emitting prostate-specific membrane antigen (PSMA) radioligands, [

Identifiants

DOI: 10.3390/cancers16111974 PMID: 38893095
pubmed: 38893095
pii: cancers16111974
doi: 10.3390/cancers16111974
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Akram Al-Ibraheem (A)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
School of Medicine, University of Jordan, Al-Jubeiha, Amman 11942, Jordan.
ORCID: 0000-0002-0978-4716

Ahmed Saad Abdlkadir (AS)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.
ORCID: 0000-0002-2009-5110

Deya' Aldeen Sweedat (DA)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.

Stephan Maus (S)

Department of Nuclear Medicine, Saarland University Medical Center, D-66421 Homburg, Germany.
ORCID: 0000-0003-1679-8080

Ula Al-Rasheed (U)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.

Samer Salah (S)

Department of Medicine, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.
ORCID: 0000-0001-7421-2522

Fadi Khriesh (F)

Department of Nuclear Medicine, Klinikum Fulda, Pacelliallee 4, 36039 Fulda, Germany.

Diyaa Juaidi (D)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.

Dina Abu Dayek (D)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.

Feras Istatieh (F)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman 11941, Jordan.

Farah Anwar (F)

Department of Nuclear Medicine, Warith International Cancer Institute, Karbala 56001, Iraq.

Aisha Asrawi (A)

Department of Nursing, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.

Alaa Abufara (A)

Department of Medicine, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.

Mohammad Al-Rwashdeh (M)

Department of Medicine, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.

Ramiz Abu-Hijlih (R)

Department of Radiation Oncology, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.
ORCID: 0000-0001-5397-6267

Baha' Sharaf (B)

Department of Medicine, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.
ORCID: 0000-0003-4368-1224

Rami Ghanem (R)

Department of Surgery, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.

Hikmat Abdel-Razeq (H)

Department of Medicine, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.
ORCID: 0000-0003-2833-6051

Asem Mansour (A)

Department of Diagnostic Radiology, King Hussein Cancer Center (KHCC), Amman 11941, Jordan.
ORCID: 0000-0003-3443-5873

Classifications MeSH